I would love to see a projector in anything. I have to say that Mr. Tokman has disappointed for years and now there doesn't seem to be any excuses if what he has told us is even close to accurate. Never ending negotiations and no supply issues, somebody has to know why nobody will sign.
If we don't have a contract signed by the Q2 CC what are the chances of one or two more dilutions as it will indicate no products this year? Looking back to last year I seem to remember Tokman indicating that he was looking for one or two by the end of 2013. If I am correct, he is way off as usual and so far this year it doesn't look to be shaping up as he predicted. HE did say Holidays in the last CC, or am I mistaken again. Seems to me he talks and talks and talks to potential customers and perhaps talks them out of signing.
YEs, but it works, over and over. Without news of substance it will continue for another month. Little catalyst until then. The RS will dominate.
Yes Anant, an update would be appreciated in light of these endless negotiations we have been in for the past severall years. If all the things Tokman has said are even close to being true why hasn't the BOD replaced him? Seems to me that even an apprentice salesman would have some success by now. I also feel that if we don't have a contract by 2nd quarter CC, then we won't have products on the street this year and that will mean one or two more dilutions to keep the paychecks rolling. Any thoughts you might have on this subject would be appreciated.
The streeet doesn't seem to think so. Maybe it has something to do with all the dillution and pending dilution. Maybe it has somehting to do with Dr. Kim and double talk about organically growing the company and then reversing course. With all we have going we should have momentum, and we did until things changed. What should be and what is seem to be out of line. Has the RS and dilution changed this from a rocket launch to a 2 year crawl? What did he mean by 2014 dwarfing 2013? Could it be he was refering to the pipeline and not the pps? Only time will tell. Nothing has changed as far as trial data or trials being initiated so the only thing I see different is dilution and the RS.
I am 72 and don't hold a lot of faith that Mr. Tokman will let me hear that sound. As long as he is still running things, there is little chance for both of us.
Is he a bad salesman or what? And that's in addition to having no credibility which is one of the major reasons no one wants to sign.
Unfortunately these "give away prices" have been a constant over the past 10 years and will continue to be until good ole' Alec gets his butt in gear and signs someone. I jumped in at "First and goal" and you don't want to know how long ago that was.
I certainly agree with that. I am looking at a 20% pull back after the RS as a target they will be buying at. Not buying now myself at this level and have decided to wait for the RS.
I"M going to catch a lot of flak on this, but here it goes. We will end up doing a 1 for 4 and reduce the float to 60M shares and get the pps to 12 or so. He will then issue another 15M shares to get to 75M and pocket $150M. We as retail would have paid up front for the huge reduction in shares and then see the value of our shares fall again with the new issued shares. Issuing shares is an easy habit to get into and it is tough on retail investors. I am inclined to agree with nova, that we are fine where we are at this point and really do not need the RS just prior to P2 results. Most had a target of $6 or so before this RS #$%$ so I am not sure where he wants the pps to be after the RS and impending news.
So much to look at over the next 8 weeks or so that will have impact to the company and the pps. P2 is huge and is a game changing event for us. All the new trials we are going to initiate will propel us into the limelight and onto everyones radar. The RS will have impact as they always do and the action will be wild. The new wrinkle is the Piper Jaffrey meeting today and what will be the out come. Piper Jaffrey always means dilution in my experience and I wouldn't put it past the good Dr. to do the RS at 1 for 4 and then turn around and issue more shares. Wash, rinse, repeat and he seems to have gotten this lesson embedded. We already know that he has lost his taste for retail shareholders by the reasons stated in the proxy for the pending RS we currently face. The volitality is going to be something to rememmber in the future. Dr. Kim has a unique set of circumstances facing him and the company which I think he willl take full advantage of inspite of his personal feelings for retail investors. As I see it, it is all about the money and the market cap. Let's hear some other thoughts.
Never knew Piper Jaffrey to do anything but issue shares. Wouldn't be surprised to see the RS finalized and an issue of an additional 10M shares. Kim knows what he wants in his hand and they are going to tell him how to get it. JMHO.
Unfortunately for investors you have hit the nail on the head. Tokman has no credibility due to his dishonesty.
Because for the past ten years the company has said it has Non Disclosure Agreements with all the companies they are talking to. Every dam one of them and they can't comment on anything. What they can talk about is issuing shares, twice a year with no contracts and we will never know why. It is up to Joe Spazz to keep us informed as to negotiations and supplies and market conditions and advancements. Not sure at this point just what The CEO does for his money, but there you have it in a nutshell. Not sure if Joe gets any pay for his services, but they are a lot more valuable to us than what that Tokman guy has provided shareholders so far.